A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

NCT03691051 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

78

Enrollment

OTHER_GOV

Sponsor class

Conditions

HER2 Positive Metastatic Breast Cancer

Interventions

DRUG: Pyrotinib plus Capecitabine

Sponsor

Henan Cancer Hospital